Matt is Deputy Head of Licensing & Ventures (Life Sciences) at Oxford University Innovation (OUI), the technology transfer company for the University of Oxford. He leads a team of Licensing & Ventures Managers who assist researchers at the University to maximise the global impact of their research and expertise through technology licensing to existing companies and University spin outs. In 13 years at OUI he has provided technology transfer support for a wide variety of University projects, including the Oxford-AstraZeneca vaccine for COVID-19 and the Oxford-Serum Institute vaccine for malaria, and has helped to spin out several University spinout companies including Vaccitech (Barinthus Biotherapeutics), MiroBio (Gilead) and Nucleome Therapeutics. His previous role was as the Intellectual Property Manager at Research & Knowledge Exchange Services within the University of Strathclyde, Glasgow, where he had responsibility for the protection and management of Strathclyde’s IP portfolio across the breadth of its research base. Matt has a PhD in Immunology from Imperial College, London and a BSc in Biomedical Sciences from the University of the West of England, Bristol.
